Flucelvax Quadrivalent (Influenza Vaccine) is the first and only cell culture-based flu vaccine in the United States to help offer protection against 4 flu virus strains for people aged 4 years and older.
Flucelvax is the first FDA-approved flu vaccine to use cells, instead of chicken eggs, and represented the first major advance in flu vaccine manufacturing technology since flu vaccine production began in the 1930s.
Flucelvax Quadrivalent is made the same way.
This modern manufacturing process allows the flu shot to be antibiotic free, helps protect against the identified 4 flu strains for 2019-2020, and is well tolerated.
Flucelvax Quadrivalent is also preservative and latex free.